Recently spun off from Medtronic as the diabetes segment. No specific operational details or outlook provided in the article to warrant a positive or negative sentiment.
MiniMed Group news
$19.29+2.33%
Close Nov 4, 2026 · split-adjustedArticles · 30 days1English, de-duplicated
Positive00% of coverage
Neutral1100%
Negative00% of coverage
About MiniMed Group
No recent articles focused on MiniMed Group.
Also mentions MMED
Articles that tag MMED but are mainly about other companies.
The Motley FoolNov 1, 12:21 AM ETNeutral
Zacks Investment ResearchSep 2, 6:10 AM ET▲ Positive
Company outpaced revenue expectations with $843 million versus estimated $828 million, driving a significant 10.7% share price jump.
The Motley FoolMay 10, 11:15 AM ETNeutral
Mentioned as recent spin-off from Medtronic. Presented as positive development for Medtronic's profitability but not independently analyzed or recommended.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology